El índice h5 es el índice h de los artículos publicados en los últimos 5 años completos. Se trata del número mayor h en cuanto a que h artículos publicados entre 2014 - 2018 deben tener al menos h citas cada uno.ocultar
La mediana h5 de una publicación es el número mediano de citas de los artículos que componen el índice h5.ocultar
Título / AutorCitado porAño
Vitamin D status and ill health: a systematic review
P Autier, M Boniol, C Pizot, P Mullie
The Lancet Diabetes & Endocrinology 2 (1), 76-89
7682014
Diabetes: a 21st century challenge
PZ Zimmet, DJ Magliano, WH Herman, JE Shaw
The Lancet Diabetes & Endocrinology 2 (1), 56-64
4342014
Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1· 9 million people
AD Shah, C Langenberg, E Rapsomaniki, S Denaxas, ...
The Lancet Diabetes & Endocrinology 3 (2), 105-113
4232015
Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study
G Li, P Zhang, J Wang, Y An, Q Gong, EW Gregg, W Yang, B Zhang, ...
The Lancet Diabetes & Endocrinology 2 (6), 474-480
4192014
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
H Yki-Järvinen
The Lancet Diabetes & Endocrinology 2 (11), 901-910
4092014
Childhood and adolescent overweight and obesity in Latin America: a systematic review
JÁ Rivera, TG de Cossío, LS Pedraza, TC Aburto, TG Sánchez, ...
The Lancet Diabetes & Endocrinology 2 (4), 321-332
3632014
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
AH Barnett, A Mithal, J Manassie, R Jones, H Rattunde, HJ Woerle, ...
The Lancet Diabetes & Endocrinology 2 (5), 369-384
3542014
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis
MJ Bolland, A Grey, GD Gamble, IR Reid
The Lancet Diabetes & Endocrinology 2 (4), 307-320
3442014
Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases
RR Kalyani, M Corriere, L Ferrucci
The Lancet Diabetes & Endocrinology 2 (10), 819-829
3372014
Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial
L Poston, R Bell, H Croker, AC Flynn, KM Godfrey, L Goff, L Hayes, ...
The Lancet Diabetes & Endocrinology 3 (10), 767-777
3142015
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study
Diabetes Prevention Program Research Group
The Lancet Diabetes & Endocrinology 3 (11), 866-875
2782015
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
RA Hegele, HN Ginsberg, MJ Chapman, BG Nordestgaard, ...
The Lancet Diabetes & Endocrinology 2 (8), 655-666
2782014
Bariatric surgery in adolescents
S Kang
LANCET DIABETES & ENDOCRINOLOGY 4 (1), 22-22
2702016
Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study
RE Pratley, MA Nauck, AH Barnett, MN Feinglos, F Ovalle, ...
The Lancet Diabetes & Endocrinology 2 (4), 289-297
2662014
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis
JHY Wu, C Foote, J Blomster, T Toyama, V Perkovic, J Sundström, B Neal
The Lancet Diabetes & Endocrinology 4 (5), 411-419
2642016
Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study
NG Forouhi, A Koulman, SJ Sharp, F Imamura, J Kröger, MB Schulze, ...
The Lancet Diabetes & Endocrinology 2 (10), 810-818
2632014
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
E Ahlqvist, P Storm, A Käräjämäki, M Martinell, M Dorkhan, A Carlsson, ...
The Lancet Diabetes & Endocrinology 6 (5), 361-369
2552018
Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial
M Ridderstråle, KR Andersen, C Zeller, G Kim, HJ Woerle, UC Broedl, ...
The Lancet Diabetes & Endocrinology 2 (9), 691-700
2492014
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study
D Saleheen, R Scott, S Javad, W Zhao, A Rodrigues, A Picataggi, ...
The Lancet Diabetes & Endocrinology 3 (7), 507-513
2472015
Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses
BM Popkin, C Hawkes
The Lancet Diabetes & Endocrinology 4 (2), 174-186
2462016
1 - 20
Las fechas y los recuentos de citas son estimados y se determinan de forma automática mediante un programa informático.